Palisade Bio EPS PALI

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026: n/m; a quarter missing
Latest quarter, Q2 FY26: −$0.05
Fiscal year 2024: −$11.78

Palisade Bio's twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.

In its latest quarter, Q2 FY26, it was −$0.05.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal year	EPS	Change
FY2024	−$11.78	n/a
FY2023	−$28.26	n/a
FY2022	−$376.05	n/a
FY2020	−$6352.50	n/a
FY2019	−$26460.00	n/a
FY2018	−$28980.00	n/a
FY2017	−$132300.00	n/a
FY2016	−$231300.00	n/a
FY2015	−$269100.00	n/a
FY2014	−$304200.00	n/a
FY2013	−$315900.00	n/a
FY2012	−$198900.00	n/a
FY2011	−$315900.00	n/a
FY2010	n/a	n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.05	n/a	n/a
Q1 FY26	Mar 31, 2026	−$0.05	n/a	n/a
Q3 FY25	Sep 30, 2025	−$0.38	n/a	−$2.98
Q2 FY25	Jun 30, 2025	−$0.58	n/a	−$4.92
Q1 FY25	Mar 31, 2025	−$0.47	n/a	−$7.66
Q4 FY24	Dec 31, 2024	−$1.55	n/a	−$11.78
Q3 FY24	Sep 30, 2024	−$2.32	n/a	−$15.05
Q2 FY24	Jun 30, 2024	−$3.32	n/a	−$20.11
Q1 FY24	Mar 31, 2024	−$4.59	n/a	−$24.72
Q4 FY23	Dec 31, 2023	−$4.82	n/a	−$28.26
Q3 FY23	Sep 30, 2023	−$7.38	n/a	−$57.04
Q2 FY23	Jun 30, 2023	−$7.93	n/a	−$111.16

Against its peers

Companies in Biotechnology nearest Palisade Bio's size, closest first, today.

Company	EPS, 12 months	Growth
PALIPalisade Bio	n/m
PLXProtalix BioTherapeutics	$0.23	+283% a year
MGTXMeiraGTx	$0.71
VCELVericel	$0.46	+283% a year
Peer median	$0.46

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Palisade Bio

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.